- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CYP3A4*22
Total 24 results
-
University of Michigan Rogel Cancer CenterWithdrawn
-
University of TurkuTurku University Hospital; Sanofi; Vaasa Central Hospital, Vaasa, Finland; medbase...CompletedCYP3A Phenotyping | CYP3A5 and MDR1 Genotyping | Docetaxel Toxicity | Associations Between Genetic Data and Docetaxel ToxicityFinland
-
Karolinska University HospitalAstraZenecaCompleted
-
PfizerCompletedPharmacokinetics | Cytochrome P-450 CYP2D6 | CYP3A4 Protein, HumanUnited States
-
Medical University of South CarolinaJohns Hopkins University; University of North Carolina; Cook Endoscopy; Thoraxklinik-Heidelberg...CompletedQuantity of Tissue Obtained | Quality of Tissue Obtained | Ease of Use of 22-gauge ProCore EBUS Needles and the Standard 22-gauge NeedlesUnited States
-
Rambam Health Care CampusUnknownGroup A- 23 Implant Using Switch Platform -SPK Abutment. | Group B- 22 Implant Using the Traditional -CPK Abutment.Israel
-
Assistance Publique - Hôpitaux de ParisCompletedPregnant Woman With Twins After 22 Weeks 0 Days of GestationFrance
-
University Hospital, Basel, SwitzerlandCompletedCytochrome P450 CYP3A Enzyme DeficiencySwitzerland
-
Hebei Senlang Biotechnology Inc., Ltd.Tongji HospitalRecruiting19 and 22+ B Cell Hematologic Tumors | 19 and 20+ B Cell Hematologic TumorsChina
-
Johns Hopkins UniversityCompletedHealthy Subjects | Cytochrome P450 CYP3A5 Enzyme Polymorphism | Pharmacokinetics of MaravirocUnited States
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
Inje UniversityCompletedHealthy Subjects | Pharmacokinetics of Three PDE5Is | Genetic Polymorphic CYP3A5
-
Poznan University of Life SciencesCompleted
-
Washington University School of MedicineNational Institute of General Medical Sciences (NIGMS)CompletedEvaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3AUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei HospitalRecruitingCD19+ and CD 22+ B-ALLChina
-
Robert Bosch Gesellschaft für Medizinische Forschung...CompletedAnovulation | Cytochrome P450 CYP3A Enzyme Deficiency | Disorder Due Cytochrome P450 CYP2D6 VariantGermany
-
University of MonastirCompletedSchizophrenia | Clozapine | CYP1A2 Polymorphism | CYP2C19 PolymorphismTunisia
-
Affiliated Hospital of Nantong UniversityNot yet recruitingDepression | Polymerase Chain Reaction | Polymorphism, Genetic | CYP1A2 Polymorphism | Plasma Concentration | CYP2C9 Polymorphism
-
Washington University School of MedicineRecruitingPregnancy Complications | Pregnancy Loss | Fetal Death | Abortion, Second Trimester | Fetal Demise | Rupture, Spontaneous | PPROM | Fetal Demise From Miscarriage | Fetal Death Before 22 Weeks With Retention of Dead FetusUnited States
-
German Cancer Research CenterUniversity Hospital HeidelbergRecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | CYP3A Inhibitor | Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic NeoplasmGermany
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
Ziqiang LiActive, not recruitingComplete and Accurate Statistical Data of 60 Patients | CYP3A5*3 Genotypes of 60 Donors and Recipients Were Analyzed Accurately | Postoperative Tacrolimus Concentrations Were Accurately Recorded in 60 Patients | According to the Diagnosis and Grading Criteria of Acute Kidney Injury, the... and other conditionsChina
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia